Novo Nordisk A/S ADR (NY: NVO )

105.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
February 13, 2012
Form SC 13G/A
Source: SEC/Edgar
February 09, 2012
Form 6-K
Source: SEC/Edgar
February 07, 2012
Form 20-F/A
Source: SEC/Edgar
February 07, 2012
Form 6-K
Source: SEC/Edgar
February 06, 2012
Form 6-K
Source: SEC/Edgar
February 05, 2012
Form 20-F
Source: SEC/Edgar
February 05, 2012
Form 6-K
Source: SEC/Edgar
February 02, 2012
Form 6-K
Source: SEC/Edgar
January 31, 2012
Form 6-K
Source: SEC/Edgar
January 23, 2012
Form 6-K
Source: SEC/Edgar
January 16, 2012
Form 6-K
Source: SEC/Edgar
January 10, 2012
Form 6-K
Source: SEC/Edgar
January 03, 2012
Form 6-K
Source: SEC/Edgar
January 02, 2012
Form 6-K
Source: SEC/Edgar
December 27, 2011
Form 6-K
Source: SEC/Edgar
December 27, 2011
Form 6-K
Source: SEC/Edgar
December 20, 2011
Form 6-K
Source: SEC/Edgar
December 12, 2011
Form 6-K
Source: SEC/Edgar
December 08, 2011
Form 6-K
Source: SEC/Edgar
December 05, 2011
Form 6-K
Source: SEC/Edgar
November 29, 2011
Form 6-K
Source: SEC/Edgar
November 20, 2011
Form 6-K
Source: SEC/Edgar
November 14, 2011
Form 6-K
Source: SEC/Edgar
November 13, 2011
Form 6-K
Source: SEC/Edgar
November 07, 2011
Form 6-K
Source: SEC/Edgar
November 07, 2011
Form 6-K
Source: SEC/Edgar
October 27, 2011
Form 6-K
Source: SEC/Edgar
October 27, 2011
Form 6-K
Source: SEC/Edgar
October 25, 2011
Form 6-K
Source: SEC/Edgar
October 17, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.